Recall — Actos
: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%.
: Following a 2011 French study linking the drug to bladder cancer, medical authorities in France and Germany suspended or banned the use of Actos. ACTOS RECALL
: The FDA requires a "black box" warning—its strongest level—on the product label to alert patients to the risk of congestive heart failure . Major Legal Settlements : In June 2011, the FDA issued a
More from
Beyond Intractability
About Beyond Intractability
Built over the last 35 years by over 500 contributors, Beyond Intractability is a free information system that supports those wanting to more constructively address conflict at all levels — from the individual to the societal. More...
Intractability Challenge
Our inability to constructively handle intractable conflict is the most serious, and the most neglected, problem facing humanity. Solving today's tough problems depends upon finding better ways of dealing with these conflicts. More...
BI Substack Newsletter
BI's free Substack newsletter highlights the latest thinking on democratic decline, hyper-polarization, intractable conflict, and what can, and is, being done to address these challenges. More...
Constructive Conflict Resource Guide
A free Guide to understanding the causes and consequences of intractable conflicts and the ways in which we can all help handle these conflicts more constructively — from the interpersonal to the societal level. More...
Full BI Knowledge Base
This section is built around the BI website's traditional format, providing access to all the resources generated over the last 35 years by Beyond Intractability. More...
Colleague, News, and Opinion Links
Organized links to the thousands of outside resources describing elements of the massively parallel effort to strengthen democracy and constructively handle intractable conflicts. More...